Literature DB >> 20720471

Role of human coronavirus NL63 in hospitalized children with croup.

Ji Yeon Sung1, Hoan Jong Lee, Byung Wook Eun, So Hee Kim, So Yeon Lee, Ju Young Lee, Kyoung Un Park, Eun Hwa Choi.   

Abstract

BACKGROUND: Human coronavirus NL63 (HCoV-NL63) has recently been implicated as a common cause of croup in children. This study was performed to evaluate viruses associated with croup in children, with an emphasis on HCoV-NL63.
METHODS: Nasopharyngeal aspirates were prospectively collected from 182 children hospitalized with croup at Seoul National University Bundang Hospital from January 2005 to June 2009. Multiplex reverse-transcriptase polymerase chain reaction was conducted for detection of 11 respiratory viruses, and medical records were reviewed.
RESULTS: Viruses were identified in 147 (80.8%) of the 182 croup patients. The 3 most commonly detected viruses were parainfluenza virus type 1 (PIV1) in 44 (24.2%) patients, HCoV-NL63 in 30 (16.5%) patients, and influenza A virus in 25 (13.7%) patients. Other detected viruses were rhinovirus in 22 (12.1%) patients, PIV type 3 and respiratory syncytial virus in 15 (8.2%) patients, human bocavirus in 8 (4.4%) patients, and several others in a few patients. Coinfections with > or = 2 viruses were found in 20 (11%) patients. HCoV-NL63 was identified primarily in winter, which coincides with the peak occurrence of croup. Patients with HCoV-NL63 infection were younger than those who were positive for PIV1 (median age 13 months versus 21 months, P = 0.006) and had shorter fever duration than influenza A virus infection (median 1.5 days versus 4 days, P = 0.000).
CONCLUSIONS: PIV1 and HCoV-NL63 were most commonly associated with patients who were hospitalized with croup. HCoV-NL63 is prevalent in winter and is associated with younger age and with shorter fever duration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20720471     DOI: 10.1097/INF.0b013e3181e7c18d

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  15 in total

Review 1.  Mechanisms of Immune Dysregulation in COVID-19 Are Different From SARS and MERS: A Perspective in Context of Kawasaki Disease and MIS-C.

Authors:  Manpreet Dhaliwal; Rahul Tyagi; Pooja Malhotra; Prabal Barman; Sathish Kumar Loganathan; Jyoti Sharma; Kaushal Sharma; Sanjib Mondal; Amit Rawat; Surjit Singh
Journal:  Front Pediatr       Date:  2022-05-05       Impact factor: 3.569

2.  Pediatrics and COVID-19.

Authors:  Tuna Toptan; Sandra Ciesek; Sebastian Hoehl
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  The nucleocapsid protein of human coronavirus NL63.

Authors:  Kaja Zuwała; Anna Golda; Wojciech Kabala; Michał Burmistrz; Michal Zdzalik; Paulina Nowak; Sylwia Kedracka-Krok; Mirosław Zarebski; Jerzy Dobrucki; Dominik Florek; Sławomir Zeglen; Jacek Wojarski; Jan Potempa; Grzegorz Dubin; Krzysztof Pyrc
Journal:  PLoS One       Date:  2015-02-20       Impact factor: 3.240

4.  Epidemiology and Clinical Features of Human Coronaviruses in the Pediatric Population.

Authors:  Litty Varghese; Philip Zachariah; Celibell Vargas; Philip LaRussa; Ryan T Demmer; Yoko E Furuya; Susan Whittier; Carrie Reed; Melissa S Stockwell; Lisa Saiman
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-15       Impact factor: 3.164

5.  Characterization of the spike protein of human coronavirus NL63 in receptor binding and pseudotype virus entry.

Authors:  Han-Xin Lin; Yan Feng; Xinming Tu; Xuesen Zhao; Chih-Heng Hsieh; Lauren Griffin; Murray Junop; Chengsheng Zhang
Journal:  Virus Res       Date:  2011-07-20       Impact factor: 3.303

6.  Development of loop-mediated isothermal amplification assay for detection of human coronavirus-NL63.

Authors:  Krzysztof Pyrc; Aleksandra Milewska; Jan Potempa
Journal:  J Virol Methods       Date:  2011-04-27       Impact factor: 2.014

7.  Human coronavirus NL63: a clinically important virus?

Authors:  Burtram C Fielding
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

8.  Epidemiological and clinical features of human coronavirus infections among different subsets of patients.

Authors:  Tatiane K Cabeça; Celso Granato; Nancy Bellei
Journal:  Influenza Other Respir Viruses       Date:  2013-03-05       Impact factor: 4.380

9.  Stability of infectious human coronavirus NL63.

Authors:  Dominik Florek; Michal Burmistrz; Jan Potempa; Krzysztof Pyrc
Journal:  J Virol Methods       Date:  2014-04-18       Impact factor: 2.014

10.  Novel polymeric inhibitors of HCoV-NL63.

Authors:  Aleksandra Milewska; Justyna Ciejka; Kamil Kaminski; Anna Karewicz; Dorota Bielska; Slawomir Zeglen; Wojciech Karolak; Maria Nowakowska; Jan Potempa; Berend Jan Bosch; Krzysztof Pyrc; Krzysztof Szczubialka
Journal:  Antiviral Res       Date:  2012-11-29       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.